Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline

Journal of the Neurological Sciences

Volumn 143, Issue 1-2, 1996, Pages 14-18

  Constantinescu, Cris S ^a   Hilliard, Brendan ^a   Lavi, Ehud ^a   Ventura, Elvira ^a   Venkatesh, Vijay ^a   Rostami, Abdolmohamad ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Cyclic AMP; Cytokine; Experimental autoimmune neuritis; Guillain Barre syndrome; Pentoxifylline; Phosphodiesterase

Indexed keywords

PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEMYELINATION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTOIMMUNE DISEASES; CAUDA EQUINA; CELL DIVISION; FEMALE; MYELIN PROTEINS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; OBSERVER VARIATION; PENTOXIFYLLINE; PERIPHERAL NERVES; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 0030297406     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00195-5     Document Type: Article

References (23)

1. Chen D., Rothenberg E.V. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:1994;931-942.
2. Dezube B.J.et al. High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. J. Infect. Dis. 171:1995;1628-1632.
3. Genain C.P.et al. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA. 92:1995;3601-3605.
4. Han J.et al. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172:1990;391-394.
5. Hartung H.P.et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 39:1992;197-210.
6. Hartung, H.P. et al. (1995) Immunopathogenesis and treatment of the Guiilain Barré syndrome. Muscle Nerve. 10: 137-153; 154-184.
7. Hecht M.et al. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from MRL-lpr/lpr mice. J. Leukoc. Biol. 57:1995;242-249.
8. Jung S.et al. Therapeutic effect of transforming growth factor-b2 on actively induced EAN but not adoptive transfer EAN. Immunology. 83:1994;545-551.
9. Lerner A.et al. Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidyl inositol phosphates in mouse T lymphocytes. J. Immunol. 140:1988;936-945.
10. Linington C.et al. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J. Immunol. 133:1984;1946-1950.
11. Maksymowych W.P.et al. An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J. Rheumatol. 22:1995;625-629.
12. Nataf S.et al. Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol. Scand. 88:1993;97-99.
13. Rieneck K.et al. In vitro immunomodulatory effects of pentoxifylline. Immunol. Lett. 37:1993;131-138.
14. Rostami A. Pathogenesis of immune mediated neuropathies. Pediatric Res. 33((suppl)):1992;90-94.
15. Rostami A.et al. Transfer of experimental allergic neuritis with P2-reactive T-cell lines. Cell. Immunol. 91:1985;354-361.
16. Rostami A.M. Guillain-Barré syndrome: clinical and immunological aspects. Springer Semin. Immunopathol. 17:1995;29-42.
17. Rostami A.M.et al. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein. J. Neuroimmunol. 30:1990;145-151.
18. Rott O.et al. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encepahlomyelitis in Lewis rats. Eur. J. Immunol. 23:1993;1745-1751.
19. Sinha B.et al. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25:1995;147-153.
20. Sommer N.et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1:1995;244-248.
21. Stoll G.et al. Tumor necrosis factor-alpha in immune mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
22. Zabel P.et al. Oxypentifylline in endotoxaemia. Lancet. 2:1989;1174-1477.
23. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:1990;579-621.